July 10, 2017 Environ, Ag./Food & Bev Liq. Handling & Robotics Product Launch

COPAN Diagnostics Launching First Fully Automated Instrument for Preparing Pour Plate Total Viable Counts (TVCs) at IAFP 2017

Milky Way for Preparing Pour Plate Total Viable Counts TAMPA, Fla., July 10, 2017 /PRNewswire/ — The MilkyWay is heading to the Sunshine State. COPAN Diagnostics, Inc. will unveil MilkyWay, the first fully automated instrument for preparing pour plate total viable bacterial counts on liquid samples, at the International Association for Food Protection Annual Conference in Tampa, Florida today. The... Read more

July 10, 2017 Environ, Ag./Food & Bev Product Launch

Neogen develops fastest Listeria test with no enrichment

CONTACT: Ed Bradley, Vice President of Food Safety, Neogen Corporation, 517/372-9200 LANSING, Mich., July 10, 2017 — Neogen Corporation (NASDAQ: NEOG) has developed an innovative test that detects Listeria in environmental samples in under 60 minutes — without the need to enrich samples. Neogen’s new Listeria Right Now™ test system can detect all species of Listeria, including the pathogenic L. monocytogenes, in... Read more

July 10, 2017 Bio/Pharma/CRO Product Launch

Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Journal of Medicine

Basel, 10 July 2017 Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Journal of Medicine HAVEN 1 showed emicizumab reduced bleed rate by 87% compared with on-demand bypassing agents All 12 secondary endpoints in HAVEN 1 were positive, including an intra-patient comparison that showed emicizumab reduced bleed rate... Read more

July 10, 2017 Bio/Pharma/CRO Product Launch

Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Journal of Medicine

Basel, 10 July 2017 Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Journal of Medicine HAVEN 1 showed emicizumab reduced bleed rate by 87% compared with on-demand bypassing agents All 12 secondary endpoints in HAVEN 1 were positive, including an intra-patient comparison that showed emicizumab reduced bleed rate... Read more

July 7, 2017 Lab Top-10 Product Launch

Agilent Technologies Opens New Customer & Technology Center in Waldbronn, Germany

WALDBRONN, Germany, July 7, 2017 Agilent Technologies Inc. (NYSE: A), today celebrated the opening of a new Agilent Customer and Technology Center at the Agilent campus in Waldbronn, Germany. Agilent executives were accompanied at the event by Katrin Schütz, state secretary in the Ministry of Economic Affairs, Labor, and Housing for the state of Baden-Württemberg;... Read more

June 29, 2017 Lab Equipment Product Launch

New FDA-Cleared Microbroth Dilution Susceptibility Testing Plate Expands Patient Treatment Options for Gram Negative Infections

New antimicrobial options, including ceftolozane/tazobactam and ceftazidime/avibactam, and extended dilution ranges enable targeted treatment recommendations (PRNewsfoto/Thermo Fisher Scientific Inc.) EAST GRINSTEAD, England, June 29, 2017 /PRNewswire/ — A new FDA-cleared microbroth dilution plate for antimicrobial susceptibility (AST) of Gram negative organisms is now available in the U.S., including two of the latest novel compounds, ceftolozane/tazobactam and ceftazidime/avibactam. The... Read more

June 29, 2017 Industrial Lab Top-10 Microscopy Product Launch

Thermo Fisher Scientific Adds Three New Products to Leading Semiconductor Portfolio

New products designed to help semiconductor failure analysis labs achieve higher volumes of samples and faster time-to-data HILLSBORO, Ore., June 29, 2017 /PRNewswire/ — For semiconductor manufacturers seeking fast, high-quality electrical and physical failure analysis, Thermo Fisher Scientific today announced three new additions to its broad portfolio of semiconductor failure analysis workflows. The company will demonstrate these products and... Read more

June 29, 2017 Bio/Pharma/CRO Product Launch

Gyros Protein Technologies introduces new ADA solution for immunogenicity market

Developed to support assay development and validation for detection of anti-drug antibodies   Uppsala, Sweden, June 29th, 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has launched a new version of its anti-drug antibody (ADA) solution for the immunogenicity market.  ... Read more